We show for the first time that pre-treating human DCs with epacadostat before they were used to stimulate peptide-specific T-cell lines derived from cancer patients resulted in increased production of IFN-γ and increased lysis of human tumor cell line targets expressing various tumor-associated antigens. Here, IFNG is linked to neoplasm.